Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Jason Aryeh

Affiliations

  • Director at Ligand Pharmaceuticals Inc (LGND), 2019-09-04
  • Large Shareholder, Other at Merrimack Pharmaceuticals Inc (MACK), 2019-07-18
  • Director at Aralez Pharmaceuticals Inc. (ARLZ), 2017-05-24
  • Director at Novelion Therapeutics Inc. (NVLN), 2017-05-17
  • Director at Immunomedics Inc (IMMU), 2017-01-11
  • Director at Myrexis Inc. (MYRX), 2012-06-20
  • Director at Nabi Biopharmaceuticals (NABI), 2011-05-27
Insider Trading: Purchases See All
Company Symbol Price Amount Relationship Remaining Holdings Date Form 4
LGND $87.01 750 Director 67,203 2019-09-03 Filing
LGND $90.01 746 Director 66,453 2019-08-05 Filing
LGND $93.00 754 Director 65,707 2019-07-31 Filing
LGND $100.22 3,000 Director 64,953 2019-07-30 Filing
LGND $106.01 250 Director 61,953 2019-07-29 Filing
Insider Trading: Sales See All
Company Symbol Price Amount Relationship Remaining Holdings Date Form 4
LGND $241.81 26,862 Director 51,392 2018-08-17 Filing
LGND $245.00 1,080 Director 78,254 2018-08-16 Filing
LGND $176.47 4,000 Director 79,334 2018-03-09 Filing
LGND $174.88 3,500 Director 83,334 2018-03-08 Filing
LGND $155.00 3,417 Director 86,834 2018-02-23 Filing